NewCardio, Inc.
NWCI
$0.00
$0.000.00%
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Revenue | 40.99% | 367.90% | 405.10% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.99% | 367.90% | 405.10% | -- | -- |
| Cost of Revenue | 76.00% | 234.44% | 1,092.43% | -- | -- |
| Gross Profit | -23.75% | 1,582.61% | -12.42% | -- | -- |
| SG&A Expenses | -34.69% | -34.79% | -29.28% | -15.82% | -1.27% |
| Depreciation & Amortization | -24.29% | -31.28% | -34.86% | -36.56% | 10.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.85% | -25.36% | -16.06% | -4.13% | 2.23% |
| Operating Income | 27.98% | 27.95% | 18.01% | 6.67% | -0.56% |
| Income Before Tax | 8.36% | 13.03% | 17.11% | -19.87% | -1,338.23% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.36% | 13.03% | 17.11% | -19.87% | -1,338.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.36% | 13.03% | 17.11% | -19.87% | -1,338.23% |
| EBIT | 27.98% | 27.95% | 18.01% | 6.67% | -0.56% |
| EBITDA | 28.24% | 28.21% | 18.25% | 6.91% | -0.26% |
| EPS Basic | 26.20% | 32.41% | 35.81% | 7.00% | -2,162.94% |
| Normalized Basic EPS | 30.52% | 35.09% | 40.46% | 6.91% | -66,733.33% |
| EPS Diluted | 26.20% | 32.41% | 35.81% | 7.00% | -2,162.94% |
| Normalized Diluted EPS | 30.52% | 35.09% | 40.46% | 6.91% | -66,733.33% |
| Average Basic Shares Outstanding | 15.94% | 19.33% | 21.23% | 20.68% | 16.67% |
| Average Diluted Shares Outstanding | 15.94% | 19.33% | 21.23% | 20.68% | 16.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
